← GENMAB A/S
| Annual Trend | FY 2016 | FY 2017 | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | — | $2.4b |
$3.0b
+27.91%
|
$5.4b
+77.39%
|
$10.1b
+88.43%
|
$8.5b
-16.11%
|
$14.6b
+72.07%
|
$16.5b
+12.87%
|
$21.5b
+30.67%
|
$3.7b
-82.72%
|
$4.1b
+11.05%
|
|
| Cost of Goods and Services Sold | — | $1.0b |
$1.4b
+40.16%
|
$2.4b
+66.74%
|
$7.6b
+217.82%
|
$6.4b
-16.11%
|
$10.9b
+72.07%
|
$226.0m
-97.94%
|
$985.0m
+335.84%
|
$238.0m
-75.84%
|
$288.0m
+21.01%
|
|
| Cost Of Revenue | — | — | — | — | — | — | $0 | — | $143.0m |
$238.0m
+66.43%
|
$288.0m
+21.01%
|
|
| Cost of product sales | — | — | — | — | — | — | — | ($33.0m) |
($143.0m)
-333.33%
|
($238.0m)
-66.43%
|
— | |
| Net Interest Income | — | — | — | — | — | — | — | — | $126.0m |
$77.0m
-38.89%
|
($139.0m)
-280.52%
|
|
| Gross Profit | — | $1.3b |
$1.6b
+18.60%
|
$3.0b
+86.95%
|
$2.5b
-15.18%
|
$2.1b
-16.11%
|
$2.1b
-1.55%
|
$16.2b
+678.28%
|
$3.0b
-81.67%
|
$3.5b
+16.92%
|
$3.8b
+10.37%
|
|
| Gross Profit (Calculated) | — | $1.3b |
$1.6b
+18.60%
|
$3.0b
+86.95%
|
$2.5b
-15.18%
|
$2.1b
-16.11%
|
$3.6b
+72.07%
|
$16.2b
+345.30%
|
$20.5b
+26.42%
|
$3.5b
-83.05%
|
— | |
| Research and development | — | — | $1.4b | $2.4b | $3.1b | $4.2b | $5.6b | $7.6b | $9.7b | $1.6b | $1.8b | |
| Research and development expenses | — | ($874.0m) | ($1.4b) | ($2.4b) | — | — | — | ($1.1b) | ($1.4b) | ($1.6b) | $1.8b | |
| Selling, General and Administrative Expense | — | — | — | — | — | $1.3b | $2.7b | $3.3b | $3.8b | $626.0m | $727.0m | |
| Restructuring And Mergern Acquisition | — | — | — | — | — | — | $0 | $0 | $43.0m | $185.0m | $262.0m | |
| Operating expenses: | ||||||||||||
| Total costs and operating expenses | — | ($1.0b) | ($1.6b) | ($2.7b) | — | — | — | ($1.6b) | ($2.1b) | ($2.7b) | — | |
| EBIT | $1.3b | $1.3b | $1.2b | |||||||||
| Interest Expense On Lease Liabilities | — | — | — | $7.0m | $9.0m | $12.0m | — | — | — | — | $269.0m | |
| Interest Expense | — | — | — | — | — | — | — | — | $18.0m | $61.0m | $269.0m | |
| Interest Income | — | — | — | — | — | — | $46.6m | — | $144.0m | $138.0m | $130.0m | |
| Net Non Operating Interest Income Expense | — | — | — | — | — | — | — | — | $126.0m | $77.0m | ($139.0m) | |
| Gain On Sale Of Security | — | — | — | — | — | — | — | — | $228.0m | $62.0m | ($27.0m) | |
| Other Income Expense | — | — | — | — | — | — | — | — | $185.0m | ($123.0m) | ($289.0m) | |
| Pre-Tax Income | — | — | — | — | — | — | — | — | $1.3b | $1.2b | $906.0m | |
| Current Tax Expense (Income) | — | — | $161.0m | $444.0m | $1.2b | $968.0m | $1.5b | $1.3b | $1.8b | $256.0m | — | |
| Deferred Tax Expense (Income) Recognised In Profit Or Loss | — | — | — | — | — | — | — | — | — | $10.0m | — | |
| Income Tax Expense Continuing Operations | — | — | $140.0m | $693.0m | $1.1b | $975.0m | $1.5b | $1.3b | $1.3b | $241.0m | $118.0m | |
| Net Income From Continuing And Discontinued Operation | — | — | — | — | — | — | — | — | $1.1b | $963.0m | $788.0m | |
| Basic Earnings (Loss) Per Share | — | $18.14 | $24.03 | $34.40 | $73.00 | $46.00 | $84.45 | $66.64 | $122.21 | $15.50 | $1.28 | |
| Diluted Earnings (Loss) Per Share | — | $17.77 | $23.73 | $34.03 | $72.21 | $45.54 | $83.65 | $66.02 | $121.36 | $15.37 | $1.27 | |
| Basic Average Shares | — | — | — | — | — | — | — | — | $641.9m | $621.5m | $616.0m | |
| Diluted Average Shares | — | — | — | — | — | — | — | — | $646.3m | $626.9m | $623.4m | |
| Additional Financial Items | ||||||||||||
| Applicable Tax Rate | — | — | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | — | |
| Auditors Remuneration For Tax Services | — | — | $400k | $500k | $300k | — | — | — | — | — | — | |
| Average Effective Tax Rate | — | — | — | — | $0 | $0 | $0 | $0 | $0 | $0 | — | |
| Depreciation Right of Use Assets | — | — | — | $28.0m | $36.0m | $56.0m | $74.0m | $87.0m | $102.0m | $17.0m | — | |
| Finance Income | — | — | $243.0m | $228.0m | $1.1b | $1.7b | $1.4b | $1.3b | $4.4b | $408.0m | — | |
| Impairment Loss Recognised In Profit Or Loss Goodwill | — | — | — | — | — | — | — | — | $0 | $0 | — | |
| Impairment Loss Recognised In Profit Or Loss Intangible Assets Other Than Goodwill | — | — | $0 | $0 | — | — | — | — | — | — | — | |
| Profit Loss Before Tax | — | — | $1.6b | $2.9b | $5.9b | $4.0b | $7.0b | $5.6b | $9.2b | $1.2b | — | |
| Profit Loss From Operating Activities | — | — | $1.4b | $2.6b | $6.3b | $3.0b | $6.4b | $5.3b | $6.7b | $1.1b | — | |
| Acquisition and integration related charges | — | — | — | — | — | — | — | $0 | ($43.0m) | ($185.0m) | — | |
| Operating profit | — | $1.3b |
$1.4b
+2.68%
|
$2.6b
+91.16%
|
$6.3b
+139.31%
|
$3.0b
-52.19%
|
$6.4b
+110.64%
|
$772.0m
-87.86%
|
$972.0m
+25.91%
|
$1.1b
+9.57%
|
— | |
| Financial income | — | $72.0m | $243.0m | $228.0m | — | — | — | $299.0m | $645.0m | $408.0m | — | |
| Net profit before tax | — | $1.1b | $1.6b | $2.9b | — | — | — | $817.0m | $1.3b | $1.2b | — | |
| Corporate tax | — | $40.0m | ($140.0m) | ($693.0m) | — | — | — | ($186.0m) | ($193.0m) | ($241.0m) | — | |
| Net profit | — | $1.1b | $1.5b | $2.2b | — | — | — | $631.0m | $1.1b | $963.0m | — | |
| Exchange differences on translation of foreign operations | — | — | — | — | — | — | — | $139.0m | ($224.0m) | $45.0m | — | |
| Diluted EPS | — | — | — | — | — | — | — | — | $1.69 | $1.54 | $1.27 | |
| Diluted NI Availto Com Stockholders | — | — | — | — | — | — | — | — | $1.1b | $963.0m | $788.0m | |
| Normalized EBITDA | — | — | — | — | — | — | — | — | $1.2b | $1.5b | $1.3b | |
| Normalized Income | — | — | — | — | — | — | — | — | $975.0m | $1.1b | $1.0b | |
| Reconciled Depreciation | — | — | — | — | — | — | $52.1m | — | $60.0m | $71.0m | $94.0m | |
| Selling General And Administration | — | — | — | — | — | — | $385.2m | $478.0m | $549.0m | $626.0m | — | |
| Special Income Charges | — | — | — | — | — | — | $0 | $0 | ($43.0m) | ($185.0m) | ($262.0m) | |
| Tax Effect Of Unusual Items | — | — | — | — | — | — | — | — | $27.0m | ($24.6m) | ($37.6m) | |
| Tax Provision | — | — | — | — | — | — | — | — | $193.0m | $241.0m | $118.0m | |
| Tax Rate For Calcs | — | — | — | — | — | — | — | — | $0 | $0 | $0 | |
| Depreciation And Amortisation Expense | — | — | $28.0m | $40.0m | $79.0m | $110.0m | — | — | — | — | — | |
| Employee Benefits Expense | — | — | $360.0m | $651.0m | $934.0m | $1.6b | $2.6b | $3.5b | $4.3b | $763.0m | — | |
| Expense From Share-Based Payment Transactions With Employees | — | — | $91.0m | $147.0m | $200.0m | $310.0m | $439.0m | $586.0m | $721.0m | $128.0m | — | |
| Expense Relating To Short-Term Leases For Which Recognition Exemption Has Been Used | — | — | — | $6.0m | $3.0m | $1.0m | — | — | — | — | — | |
| Finance Costs | — | — | $11.0m | $7.0m | $1.6b | $702.0m | $680.0m | $942.0m | $2.0b | $269.0m | — | |
| Postemployment Benefit Expense Defined Benefit Plans | — | — | $24.0m | $39.0m | $51.0m | $80.0m | $112.0m | $170.0m | $205.0m | $34.0m | — | |
| Financial expenses | — | ($352.0m) | ($11.0m) | ($7.0m) | — | — | — | ($254.0m) | ($291.0m) | ($269.0m) | — | |
| Operating Expense | — | — | — | — | — | — | $1.2b | — | $2.0b | $2.2b | $2.5b | |
| Net Foreign Exchange Loss | — | — | — | — | $1.5b | $1.5b | — | $889.0m | $1.6b | — | — | |
| Total comprehensive income | — | $1.1b | $1.5b | $2.2b | — | — | — | $770.0m | $909.0m | $1.0b | — | |
| Total Unusual Items | — | — | — | — | — | — | — | — | $185.0m | ($123.0m) | ($289.0m) | |
| Total Expenses | — | — | — | — | — | — | $1.2b | — | $2.1b | $2.5b | $2.5b |
Values abbreviated: b = billions, m = millions, k = thousands. Per share data in USD.